Search
Allogene Therapeutics Inc
ALLOAdd to Watchlist
2.080USD
-0.030-1.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
477.18MMarket Cap
LossP/E TTM
Allogene Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
-0.87
34.57%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its current assets were 257.75M, with a year-on-year change of -15.04.
What are the total assets of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its total assets of Allogene Therapeutics Inc were 415.90M, with a year-on-year change of -24.20.
What are the total liabilities of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its total liabilities of Allogene Therapeutics Inc were 123.36M, with a year-on-year change of -2.50.
What is the total equity of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its total equity of Allogene Therapeutics Inc was 292.54M, with a year-on-year change of -30.71.
What is the net investment of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its net investment of Allogene Therapeutics Inc was 95.56M, with a year-on-year change of 26.25.
What is the net financing of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its net financing of Allogene Therapeutics Inc was 30.16M, with a year-on-year change of -74.15.
What is the Earnings Per Share (EPS) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.87, with a year-on-year change of 34.57.
What is the Return on Equity (ROE) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -53.42, with a year-on-year change of 3.12.
What is the Return on Assets (ROA) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -39.58, with a year-on-year change of 8.46.
What is the operating profit of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its operating profit was -206.93M, with a year-on-year change of 19.63.